Spectral AI, Inc. Q4 2025 Earnings Call Summary

Core Insights - The transition from clinical validation to regulatory submission was a defining aspect of performance in 2025, highlighted by the June de novo application for the DeepView burn indication [1] - The DeepView system is positioned as a critical triage tool for mass casualty events, addressing the need for rapid surgical burden management and resource allocation [1] - The AI-driven system demonstrated significant performance improvements over the clinical judgment of burn physicians in a validation study involving 164 patients across 15 centers [1] Financial Position - The company's financial position has strengthened due to successful debt and equity financings, resulting in a tripling of the cash balance to $15.4 million by year-end [1] - A partnership with BARDA is a key driver of development, with a recent award of $31.7 million aimed at accelerating feature enhancements such as EHR integration [1] Operational Focus - The operational focus has shifted towards building commercial infrastructure, including engaging external consultants to refine the go-to-market strategy for 2026 [1]